Anemia & HIV/AIDS: Research & News
- Study Finds Epoetin Alfa Improves Anemia in HIV/HCV-Coinfected Patients (August 2005)
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
- HIV/AIDS Anemia: Prevalence and Severity of Anemia Increases With Advancing HIV Disease (July 14, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Early Diagnosis and Appropriate Treatment of HIV-Related Anemia Important to Survival of the HIV-Positive (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Mild to Moderate Anemia Remains Common in HIV Patients (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from TheBodyPRO.com
- Counterfeit Procrit Alert (March 12, 2003)
From U.S. Food and Drug Administration
- Zidovudine-Related Anemia With Reticulocytosis (March 2003)
In Annals of Hematology
- Greater Prevalence of Anemia in Women and African Americans With HIV/AIDS in the HAART Era: A Study of 10,000 Patients (October 26, 2002)
In 40th Annual Meeting of the Infectious Diseases Society of America, from TheBodyPRO.com
- Once-Weekly Epoetin Alfa Corrects Hemoglobin and Improves Quality of Life as Effectively as Three-Times Weekly Dosing in HIV-Positive Patients (July 11, 2002)
In The XIV International AIDS Conference, from TheBodyPRO.com
- Important Drug Warning: Counterfeiting of Procrit (June 7, 2002)
To read PDF, click here.
From U.S. Food and Drug Administration
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
